Skip to main content
. 2010 Dec 29;5(12):e15291. doi: 10.1371/journal.pone.0015291

Figure 3. Biomarker levels at admission and follow up.

Figure 3

Plasma levels of biomarkers were measured at admission and 28 days post-treatment in a cohort of retinopathy positive children with cerebral malaria. Wilcoxon signed rank test with Holms correction (9 pair-wise comparisons) was used to compare levels of (A) Ang-2 (ng/mL); sum of signed ranks (W), (W, p-value: 746, p<0.0009); (B) Ang-1 (ng/mL), (W, p-value: āˆ’741, p<0.0009); (C) Ang-2:Ang-1, (W, p-value: 741, p<0.0009); (D) VWF propeptide (nM), (W, p-value: 768, p<0.0009); (E) VWF (nM), (W, p-value: 740, p<0.0009); (F) sTie-2 (ng/mL) (W, p-value: 754, p<0.0009); (G) sICAM-1 (ng/mL), (W, p-value: 732, p<0.0009); (H) VEGF (ng/mL), (W, p-value: āˆ’388, pā€Š=ā€Š0.001); and (I) IP-10 (ng/mL), (W, p-value: 607, p<0.0009).